Photo 216261582 © Axel Bueckert |

‘Lab on a chip’ genetic test device can identify viruses within three minutes

Dec. 4, 2023
Compact genetic testing device created for COVID-19 could be used to detect a range of pathogens, or conditions including cancer.
Courtesy of Abbott

Abbott receives FDA approval for HPV test to run on Alinity m

Nov. 20, 2023
Offering primary HPV screening and assessment of high-risk cancer-causing types of HPV.
Photo 176460444 © Olga Ostapenko |
Dreamstime Xxl 176460444

Understanding clinician perspective for a successful point-of-care urine drug screen test implementation

Though it is known that point-of-care (POC) urine drug screening (UDS) has its limitations, clinicians request POC UDS due to its convenience and cost effectiveness. Common clinical...
Photo 199955480 © Arne9001 |

Optimizing STI testing with vaginal swab sampling

Nov. 20, 2023
Sexually transmitted infection (STI) rates are continuing to increase, especially among young people in their teens and early twenties. From 2020 to 2021, we have seen rates rise...
Photo 213977866 © Prostockstudio |

Actionable answers: Targeted multiplex PCR respiratory testing at the point of care

Nov. 20, 2023
In the unpredictable post-COVID-19 pandemic era, patient expectations have shifted when it comes to diagnostic testing. Americans are more educated about diagnostic testing than...
Photo 129150195 © Designer491 |

Geneoscopy signs multi-year agreement with Labcorp to distribute noninvasive multi-target stool RNA (mt-sRNA) colorectal cancer screening test

Nov. 17, 2023
Collaboration expected to increase provider and patient access to potentially life-saving colorectal cancer screening that enables earlier disease detection.
Photo 49555931 © Kts |

Oxford Nanopore and Day Zero Diagnostics partner to develop a new class of bloodstream infection diagnostics

Nov. 17, 2023
According to the World Health Organization (WHO), there are 11 million sepsis-related deaths every year, accounting for one in five deaths worldwide.
Photo 2151588 © Goran Cakmazovic |

Can personalized care prevent over screening for colorectal cancer in older adults?

Nov. 15, 2023
Study reveals presenting adults between 76 and 85 with personalized information about the benefits and harms of colon cancer screening decreases excess screening.
Photo 50371595 © Designer491 |
Photo 73345087 © Angellodeco |

Drawing a tube of blood could assess ALS risk from environmental toxin exposure

Nov. 15, 2023
The risk score included 36 pollutants persistently found in the environment.
Photo 58143667 © Sherry Young |

Quest Diagnostics launches mobile phlebotomy service, enabling convenient at-home specimen collection in the United States

Nov. 13, 2023
Quest Mobile has 5,000 trained mobile phlebotomists whose reach will extend to 44 states by the end of 2023.